Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Anwar Hashem and Rowa Alhabbab.
Anwar Hashem
Connection Strength
2.488
Rowa Alhabbab
  1. Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia. Viruses. 2021 07 20; 13(7).
    View in: PubMed
    Score: 0.957
  2. Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1. Vaccines (Basel). 2021 Aug 04; 9(8).
    View in: PubMed
    Score: 0.240
  3. Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies. Pathogens. 2020 Dec 19; 9(12).
    View in: PubMed
    Score: 0.230
  4. Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients. Viruses. 2020 12 04; 12(12).
    View in: PubMed
    Score: 0.229
  5. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients. Sci Rep. 2020 10 06; 10(1):16561.
    View in: PubMed
    Score: 0.227
  6. Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011-2016. J Infect Public Health. 2020 May; 13(5):697-703.
    View in: PubMed
    Score: 0.216
  7. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model. J Infect Dis. 2019 10 08; 220(10):1558-1567.
    View in: PubMed
    Score: 0.212
  8. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein. Sci Rep. 2017 03 23; 7:44875.
    View in: PubMed
    Score: 0.177
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.